Types of Immunotherapy Available in India

Summary: Discover how immunotherapy is revolutionizing the treatment of specific types of cancers and immune related disorders. Understanding the different types helps patients find the right treatment for their conditions.

Over the last ten years, immunotherapy has altered the face of current medicine in a dramatic way, especially in cancer treatment. In contrast to chemotherapy or radiation that go directly to killing the cancer cells, immunotherapy is a way of enhancing or altering the immune system so that it is capable of identifying and attacking abnormal cells.

India, over the last few years, has considerably boosted its cancer fighting facilities, thus advanced immunotherapy treatments have been made available through specialized centers. There are, however, different mechanisms, separate indications, and the need for thorough medical consideration that are characteristic features of each kind. The differences between them should be well understood before embarking on a treatment journey. Let’s explore.

What Is Immunotherapy?

In simple terms, immunotherapy refers to a process of improving the immune system in the patient’s body to fight the disease. To talk about cancer care, it helps in identifying and eliminating tumor cells that might be overlooked by other conventional treatments.

Immunotherapy differs from conventional treatments in the following ways:

• Activation of the immune system
• Induction of immune memory
• Decreased systemic toxicity in certain cases

However, It is not a universal solution that may be applicable to all patients or all types of cancers.

Types of Immunotherapy Available for Cancers in India

Immune Checkpoint Inhibitors

Checkpoint inhibitors are the class of immunotherapeutic agents most frequently used in India.

• They function by blocking proteins such as PD-1, PD-L1, or CTLA-4, which are known to stop immune cells from attacking cancer.
• The main field of their utilization is lung cancer, melanoma, and some gastrointestinal cancers.
• The mode of administration of these drugs is intravenous infusion.

On the one hand, these drugs have been demonstrated to increase the life span of certain patients, but on the other hand, they can also lead to immune, related side effects.

Used for

• Lung cancer
• Melanoma
• Urothelial cancer
• Head & neck cancers

CAR-T Cell Therapy

One of the treatments that patients look for is chimeric antigen receptor T-cell (CAR-T) therapy, which is considered one of the most advanced types of immunotherapy.

• The patient’s T-cells are harvested and engineered in a laboratory
• The engineered cells are re-administered to specifically attack cancerous cells
• Mainly employed for the treatment of certain types of blood cancers like leukemia and lymphoma

India has started the provision of approved CAR-T therapies in regulated environments. Although very promising, CAR-T therapy needs specialized infrastructure.

Monoclonal Antibody Therapy

Scientists often develop monoclonal antibodies in the laboratory as proteins that target specific antigens on cancer cells in the patient body.

• They can tag cancer cells for destruction by the immune system
• Some of them contain targeted toxins or radiation
• They can be used for various types of cancers

These are commonly used in Indian cancer treatment centers.

Cancer Vaccines

Cancer vaccines are meant to initiate the immune response against tumor, specific antigens.

• Preventive vaccines (like the HPV vaccine) reduce cancer risk
• Therapeutic vaccines are a subject of research in cancer treatment

The work in India is progressing and mostly the therapeutic vaccines are still in the clinical trial phase.

Cytokine Therapy

Cytokines refer to the immune system proteins that stimulate the immune response.

• Examples include interleukins and interferons
• Used in treating certain cancers such as melanoma and renal cell carcinoma
• It can cause systemic side effects

Although older than the checkpoint inhibitors, cytokines are still used in immunotherapy.

Availability Of Immunotherapy in India for Cancers

In the last few years, medical science in India has evolved drastically, offering patients with multiple immunotherapy options through accredited healthcares. Here what patients treatment depends on:

• Cancer type and stage
• Genetic and biomarker testing
• Regulatory approval status
• Infrastructure & monitoring facilities

Understood that, immunotherapy needs further more evaluation such as molecular diagnostics and immune profiling. However, consulting with experts is important before undergoing such treatments.

Fortunately, Global Regenex shines the brightest in providing patients with assistance by reviewing their medical history, coordinating with specialist options, and helping them find the best healthcare for their condition.

Putting It All Together

Immunotherapy is revolutionizing cancer treatment in India, providing targeted and life-saving alternatives to conventional therapies. Patients can seek expert advice from specialists such as Global Regenex to navigate the latest treatment options.

Frequently Asked Questions

Q1. Are immunotherapy treatment options available in India?

Ans. Yes, immunotherapy treatment is available in India for different types of cancers.

Q2. Is CAR-T cell therapy approved in India?

Ans. Yes, it is approved and available in India for limited blood cancers.

Q3. Is immunotherapy more effective than chemotherapy?

Ans. Yes, immunotherapy is different from chemotherapy. It offers targeted benefits and has different eligibility from patient to patient.

Q4. Who is eligible for immunotherapy treatment in India?

Ans. Eligibility criteria for immunotherapy treatment in India are based on cancer stages, test results, overall health conditions, and oncologist recommendations.

Q5. How does Global Regenex assist patients undergoing immunotherapy treatment?

Ans. Global Regenex assists patients undergoing immunotherapy treatment in India through consultation, case evaluation, specialist coordination, and recommendations for appropriate immunotherapy treatment options.

Reference Links

U.S. National Cancer Institute – Types of Immunotherapy Explained

https://www.cancer.gov/about-cancer/treatment/types/immunotherapy

(Details immune checkpoint inhibitors, T-cell transfer therapy, monoclonal antibodies, cytokines, and vaccines used in cancer care.)

Cancer Research Organization – Immunotherapy Treatment Categories

https://www.cancerresearch.org/immunotherapy-by-treatment-types

(Lists immunotherapy classes such as adoptive cell therapy, vaccines, oncolytic viruses, immunomodulators, and targeted antibodies.)

NIH – Overview of Cancer Immunotherapy Advances

https://www.nih.gov/about-nih/nih-turning-discovery-into-health/promise-precision-medicine/cancer-immunotherapy

(Describes decades of immunotherapy drug development and precision medicine applications.)

National Cancer Institute – CAR T Cells & Engineering

https://www.cancer.gov/about-cancer/treatment/research/car-t-cells

(Explains how CAR-T therapy genetically modifies a patient’s T cells to fight cancer.)

PubMed Central – T-Cell Transfer & CAR-T Immunotherapy

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263928/

(Summarizes emerging CAR-T innovations and cellular immunotherapy trends.)

National Cancer Institute – Immune Checkpoint Inhibitors

https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors

(Explains how checkpoint inhibitors block immune “off” signals to empower T cells against cancer.)